来曲肽对比度拉糖肽治疗中国2型糖尿病
In a landmark phase 3 clinical trial, researchers have unveiled compelling evidence positioning mazdutide, a novel dual glucagon and glucagon-like ...
In a landmark phase 3 clinical trial, researchers have unveiled compelling evidence positioning mazdutide, a novel dual glucagon and glucagon-like ...
In an era marked by monumental advances in the treatment of type 2 diabetes (T2D), a persistent challenge remains: developing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine